The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis

被引:40
|
作者
Gao, Fei [1 ]
Zhou, Bin [2 ]
Xu, Jun-Chi [3 ]
Gao, Xin [1 ]
Li, Shu-Xiang [1 ]
Zhu, Geng-Chao [1 ]
Zhang, Xue Guang [2 ]
Yang, Chen [1 ]
机构
[1] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou 215000, Jiangsu, Peoples R China
[2] Soochow Univ, Inst Clin Immunol Jiangsu Prov, Suzhou 215007, Peoples R China
[3] Fifth Peoples Hosp Suzhou, Suzhou, Jiangsu, Peoples R China
关键词
LGR5; ALDH1A1; NSCLC; Clinical pathology; Prognosis; STEM-CELLS; EXPRESSION; IDENTIFICATION; PROMISE; MARKER; COLON;
D O I
10.1016/j.bbrc.2015.04.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Leucine rich repeat containing G protein coupled receptor 5 (LGR5), may be a candidate marker of non-small cell lung cancer (NSCLC) cells with stem cell-like properties. Aldehyde dehydrogenase 1A1 (ALDH1A1) is one of NSCLC stem cell markers. To identify the relationship of LGR5 and ALDH1A1 in NSCLC, we analyzed the expression of LGR5 and ALDH1A1 in NSCLC samples, and determined their clinical significance. We performed quantitative RT-PCR for LGR5 and ALDH1A1 expression in 24 NSCLC patients, and showed that LGR5 and ALDH1A1 mRNA were frequently increased in NSCLC tissues in comparison to that in adjacent normal tissues (p = 0.0005 and p < 0.0001, respectively). Besides, the expression of LGR5 and ALDH1A1 mRNA has a significant correlation (r = 0.416, P = 0.0483). The expression of LGR5 and ALDH1A1 in 109 NSCLC tumors and 50 adjacent normal tissues were detected by immunohistochemistry. Positive LGR5 and ALDH1A1 expression was defined in 28.4% and 41.3% of the NSCLC tumors, respectively. Further analysis indicated that 24 of these LGR5(+) (24/31) samples expressed ALDH1A1(r = 0.3883, p < 0.0001), we also found co-localization of LGR5 and ALDH1A1 in tumor tissue samples. LGR5 and ALDH1A1 expression was significantly associated with higher pathological TNM stage of the disease (stage I + II and III + IV) (P = 0.0311 and p = 0.0221, respectively), the co-expression of LGR5 and ALDH1A1 was associated with nodal status (p = 0.0424). High expression of LGR5 or ALDH1A1 was related to poor prognosis (P = 0.0125 and p = 0.0410, respectively), and NSCLC patients with co-expression of LGR5 and ALDH1A1 had a poorer prognosis than the others (P = 0.0011). Both of them can be an independent risk factor of a poorer prognosis (P = 0.016 and P = 0.024, respectively). The expression of LGR5 and ALDH1A1 were closely associated with the tumorigenicity, metastasis and poor prognosis of NSCLC, and LGR5+ cells in NSCLC were likely to be the cancer cells with stem cell-like properties due to the significant correlation between LGR5 and ALDH1A1. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 50 条
  • [41] SBRT for Stage 1 Non-Small Cell Lung Cancer
    Eriguchi, Takahisa
    Takeda, Atsuya
    Kimura, Yuto
    Sanuki, Naoko
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (04): : 1088 - 1089
  • [42] USO1 in non-small cell lung cancer
    Keogh, Anna
    Ryan, Lisa
    Nur, Mutaz
    Baird, Anne-Marie
    Finn, Stephen
    Gray, Steven
    LUNG CANCER, 2021, 156 : S2 - S2
  • [43] RIOK1 is associated with non-small cell lung cancer clinical characters and contributes to cancer progression
    Wang, Rong
    Chai, Wen-Shu
    Pan, Dian-Zhu
    Shan, Li-Na
    Shi, Xuan
    He, Yu-Hai
    Pan, Shuang
    JOURNAL OF CANCER, 2022, 13 (04): : 1289 - 1298
  • [44] Downregulation of ARID1A is correlated with poor prognosis in non-small cell lung cancer
    Wang, Tao
    Guo, Jinyan
    Liu, Wenhua
    Guo, Qi
    Cheng, Lvhuan
    Zheng, Renshan
    Hu, Xinchun
    TRANSLATIONAL CANCER RESEARCH, 2020, 9 (08) : 4896 - 4905
  • [45] Fascin-1 overexpression predicts a poor prognosis in non-small cell lung cancer
    Li, Dan
    Li, Weimin
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [46] The overexpression of KIFC1 was associated with the proliferation and prognosis of non-small cell lung cancer
    Liu, Yafang
    Zhan, Ping
    Zhou, Zejun
    Xing, Ze
    Zhu, Suhua
    Ma, Chenhui
    Li, Qian
    Zhu, Qingqing
    Miao, Yingying
    Zhang, Jianya
    Lv, Tangfeng
    Song, Yong
    JOURNAL OF THORACIC DISEASE, 2016, 8 (10) : 2911 - 2923
  • [47] Correlations of the ZEB1 expression with the incidence and prognosis of non-small cell lung cancer
    Ma, D-J
    Liu, H-S
    Li, S-Q
    Qin, Y-Z
    He, J.
    Cui, Y-S
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (04) : 1528 - 1535
  • [48] Programmed Death-Ligand-1 Expression in Non-Small Cell Lung Cancer and Prognosis
    Sahin, Songul
    Batur, Sebnem
    Aydin, Ovgu
    Ozturk, Tulin
    Turna, Akif
    Oz, Buge
    BALKAN MEDICAL JOURNAL, 2019, 36 (03) : 184 - 189
  • [49] Prognosis of Unexpected and Expected Pathologic N1 Non-Small Cell Lung Cancer
    Shin, Sumin
    Kim, Hong Kwan
    Choi, Yong Soo
    Kim, Kwhanmien
    Kim, Jhingook
    Shim, Young Mog
    ANNALS OF THORACIC SURGERY, 2013, 96 (03): : 969 - 976
  • [50] FOXD1 Expression Is Associated with Poor Prognosis in Non-small Cell Lung Cancer
    Nakayama, Sohei
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Yoda, Satoshi
    Satomi, Ryosuke
    Ikemura, Shinnosuke
    Terai, Hideki
    Sato, Takashi
    Yamaguchi, Norihiro
    Hamamoto, Junko
    Arai, Daisuke
    Ishioka, Kota
    Ohgino, Keiko
    Naoki, Katsuhiko
    Betsuyaku, Tomoko
    ANTICANCER RESEARCH, 2015, 35 (01) : 261 - 268